Liliana buys LMNX 17.98: Luminex doubles analysts' Q2 net income forecasts, boosts revenue
Luminex shares reached as high as $19.60 on Tuesday, before closing at $19, up $1.43 or 8 percent in heavy volume. Luminex (Nasdaq: LMNX) develops, manufactures and markets proprietary biological testing technologies with applications throughout the life . ... ...
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home